SCHEDULE 13G 0001767788 XXXXXXXX LIVE Common Stock 12/30/2024 0001518906 TriSalus Life Sciences Inc. 89680M101 6272 W. 91st Ave. Westminster CO 80031 Rule 13d-1(b) Lombard International Assurance S.A. b N4 0.00 0.00 0.00 0.00 0.00 N 0 FI Lombard International Assurance S.A. was acquired by Utmost Group PLC on 30/12/2024. Shareholdings of Lombard International Assurance S.A. were disclosed on 21/10/2024, accession number 0001104659-24-110077 TriSalus Life Sciences Inc. 6272 W. 91st Ave. Westminster, CO, 80031 Lombard International Assurance S.A. 4, rue Lou Hemmer L-1748 Luxembourg Luxembourg N FI an insurance undertaking or reinsurance undertaking authorized in accordance with Directive 2009/138/EC 0 shares 0.00 0 None 0 None N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to (J) A non-U.S. institution that is the functional equivalent of any of the institutions listed in SS240.13d-1 (b)(1)(ii)(A) through (I), so long as the non-U.S. institution is subject to a regulatory scheme that is substantially comparable to the regulatory scheme applicable to the equivalent U.S. institution is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D. Lombard International Assurance S.A. /s/ Nadine Provost 01/06/2025 /s/ Thierry Leung 01/06/2025